What is the significance of a DHEA‑S (dehydroepiandrosterone sulfate) level of 199 ng/dL and how should it be evaluated and managed?

DHEA-S Level of 199 ng/dL: Clinical Significance and Management

A DHEA-S level of 199 ng/dL is low and requires interpretation based on age, sex, and clinical context—this value may indicate adrenal insufficiency, autonomous cortisol secretion, or simply age-related decline, and should prompt evaluation of the hypothalamic-pituitary-adrenal (HPA) axis.

Understanding the Value

DHEA-S levels decline progressively with age, so 199 ng/dL may be:

• Normal in elderly patients (>70 years)
• Low in younger adults, particularly women under 50 or men under 60
• Pathologically suppressed if accompanied by other hormonal abnormalities

The key is that DHEA-S alone cannot diagnose adrenal insufficiency—it serves as a useful screening marker but requires confirmation with cortisol testing 1.

When Low DHEA-S Suggests Primary Adrenal Insufficiency (PAI)

Low DHEA-S levels well below the age- and sex-adjusted reference range are a useful initial sign of PAI, though they cannot be used in isolation 1. The diagnostic approach:

Confirm with Cortisol Testing

1. Measure morning cortisol (8-9 AM) and ACTH simultaneously

   • If cortisol <140 nmol/L (5 μg/dL) AND ACTH >2-fold above upper limit: PAI is highly likely 1
   • If cortisol >500 nmol/L (18 μg/dL): PAI is excluded

2. Perform ACTH stimulation test for confirmation

   • Standard 250 μg cosyntropin test is the gold standard
   • Measure cortisol at baseline, 30, and 60 minutes
   • Normal response excludes PAI 1

Key Point on DHEA-S Diagnostic Value

A normal age- and gender-specific DHEA-S level makes corticotropin deficiency extremely unlikely 2. However, when DHEA-S is low, further testing is mandatory—sensitivity for diagnosing adrenal insufficiency ranges from 70-87%, with specificity around 87% 3.

When Low DHEA-S Suggests Autonomous Cortisol Secretion

Paradoxically, low DHEA-S can also indicate mild autonomous cortisol secretion (MACS) from an adrenal adenoma, as excess cortisol suppresses ACTH and subsequently DHEA-S production 4, 5.

Evaluation for MACS

If an adrenal incidentaloma is present:

1. Perform 1-mg overnight dexamethasone suppression test

   • Post-dexamethasone cortisol >1.8 μg/dL suggests MACS 6

2. Calculate DHEA-S/post-DST cortisol ratio

   • Ratio <0.99 (when age-sex corrected) has 64% sensitivity and 81% specificity for cortisol-producing adenoma 7, 5
   • This ratio performs better than DHEA-S alone (AUC 0.884) 5

3. Measure ACTH

   • Suppressed ACTH with low DHEA-S supports autonomous cortisol production 6

Important caveat: In unselected adrenal incidentalomas, suppressed DHEA-S has poor predictive value (sensitivity 0.60, specificity 0.75) for hormonal activity 8. Use it as part of a comprehensive evaluation, not in isolation.

Management Based on Underlying Cause

If Primary Adrenal Insufficiency is Confirmed

Initiate glucocorticoid replacement immediately 1:

• Hydrocortisone 15-25 mg daily in 2-3 divided doses (two-thirds morning, one-third early afternoon)
• Add fludrocortisone 50-100 μg daily for mineralocorticoid replacement 1

Consider DHEA replacement in women with persistent symptoms 9, 1:

• Only if low libido, depressive symptoms, or low energy persist despite optimized glucocorticoid/mineralocorticoid replacement
• Start with 25-50 mg daily for 6 months 9
• Monitor morning DHEA-S levels (aim for mid-normal range) 1
• Discontinue if no sustained benefit after 6 months 1

Critical point: DHEA replacement is controversial with limited objective evidence of benefit 10. The 2016 Endocrine Society guideline gives it only a weak recommendation (2QQEE) 1.

If MACS is Confirmed

• Consider adrenalectomy for patients with metabolic complications (hypertension, diabetes, osteoporosis) 6
• Perioperative glucocorticoid coverage is mandatory 6
• Post-operative assessment for HPA axis recovery required 6

If Age-Related Decline Only

• No intervention needed
• DHEA-S levels naturally decline with age, especially after age 30
• Supplementation in healthy aging individuals lacks strong evidence for benefit 11

Common Pitfalls to Avoid

1. Don't diagnose adrenal insufficiency based on DHEA-S alone—always confirm with cortisol and ACTH testing 1

2. Don't assume low DHEA-S always means underproduction—it can indicate ACTH suppression from autonomous cortisol secretion 4

3. Don't use DHEA-S to monitor glucocorticoid replacement—clinical assessment is preferred 1

4. Don't routinely supplement DHEA without specific symptoms—evidence for benefit is limited, particularly in men and asymptomatic women 10

5. Don't forget age and sex adjustment—reference ranges vary dramatically across age groups 1

Immediate Next Steps

Order these tests now:

• Morning (8-9 AM) cortisol and ACTH
• Electrolytes (sodium, potassium)
• If adrenal mass present: 1-mg dexamethasone suppression test
• Consider 250 μg ACTH stimulation test if morning cortisol is indeterminate (between 5-18 μg/dL)

Assess clinically for:

• Fatigue, weakness, weight loss, hyperpigmentation (PAI signs)
• Salt craving, orthostatic hypotension (mineralocorticoid deficiency)
• Hypertension, hyperglycemia, central obesity (cortisol excess)
• Recent glucocorticoid use (iatrogenic suppression) 12